Skip to main content
. 2017 Jun 2;20(3):313–323. doi: 10.1093/neuonc/nox106

Table 2.

Preclinical miRNA studies in medulloblastoma

miRNA Mechanism Cell Line Administration Carrier Format Tumor Site Effect Reference
miR-124 overexpression D425 In vitro Lentivirus Flank/intracranial Growth inhibition 73
miR-192 miRNA mimics D283 In vivo, intranasal Nanoparticle Intracranial Metastases Inhibition 85
miR-34a Overexpression Daoy In vitro Adenovirus Flank/intracranial Growth inhibition 54
miR-199b-5p Overexpression Daoy In vitro Adenovirus Flank/intracranial Growth inhibition 52
miR-31 Overexpression Daoy In vitro Transfection Flank Growth inhibition 74
miR17‒92 Anti-miRNA Ptch1+/−, Trp53 −/− medulloblastoma cells In vivo, intra venously LNA Flank/intracranial Growth inhibition 40